Company: RGNX
Filing Date: 2025-04-08
Form Type: DEF 14A
Source: 0000950170-25-052069
Chunk: 43

Company: REGENXBIO Inc.
Filing Date: 2025-04-08
Form: DEF 14A
Chunk 43
---
 control on their job security |

The elements of our 2024 executive compensation program and compensation decisions for NEOs are described in further detail below. Base Salary Our Compensation Committee reviews and sets base salaries for NEOs, other than the President and CEO, on an annual basis in January of each year. Our Board determines the base salary for our President and CEO based on the recommendation of the Compensation Committee. Our Compensation Committee and Board seek to establish and maintain base salaries for each position and level of responsibility that are competitive with those of executives at our peer group companies. In determining the base salary for each executive, the Compensation Committee takes many factors into account, including but not limited to: • the competitive benchmark data provided by the compensation consultant; • the scope and strategic impact of the executive’s responsibilities; • the experience level of the executive; • the executive’s performance against objectives for the year, leadership and contribution to the objectives of the Company; • relative compensation levels between executives; and • input from the President and CEO (for each executive other than the President and CEO).

<div align='center'>31</div>

Our NEOs were given merit increases to their base salaries in 2024 as a result of their respective performances in 2023. In consideration of the factors described above, the base salaries for our NEOs were adjusted as follows in 2024:

| Name                 |     | Annual Base 
      Salary 
 Approved in 
        2024 
         ($) |     | Annual Base 
      Salary 
 Approved in 
        2023 
         ($) |     | Percentage   
 Increase     
 from         
 2023 to 2024 |
| Curran Simpson(1)    |     |     610,000 |     |     512,928 |     | 18.9%        |
| Mitchell Chan(2)     |     |     490,000 |     |         N/A |     | N/A          |
| Stephen Pakola, M.D. |     |     518,082 |     |     498,156 |     | 4.0%         |
| Olivier Danos, Ph.D. |     |     522,348 |     |     502,257 |     | 4.0%         |
| Patrick J. Christmas |     |     500,868 |     |     470,299 |     | 6.5%         |
| Kenneth T. Mills(3)  |     |     676,790 |